In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Cambridge NeuroScience receives two U.S. Patents
Cambridge Neuroscience and Allergan extend collaboration
Bolder BioTechnology awarded SBIR grant
TransMolecular awarded Phase II SBIR grant
Althea awarded technology grant
American Biogenetic received Japan neuroscience patent
Cambridge NeuroScience licenses growth factor
Arena awarded Phase I SBIR grant to develop antipsychotics
Inhibitex awarded SBIR grant for vaccine development
Molecular Staging awarded SBIR grant to develop biomarker chip
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
